Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin.

Borate, Uma

Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin. [electronic resource] - Leukemia research May 2016 - 25-31 p. digital

Publication Type: Case Reports; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

1873-5835

10.1016/j.leukres.2016.02.010 doi


Adult
Aged
Brentuximab Vedotin
Female
Follow-Up Studies
Humans
Immunoconjugates--therapeutic use
Immunoenzyme Techniques
Ki-1 Antigen--metabolism
Male
Mastocytosis, Systemic--drug therapy
Middle Aged
Neoplasm Staging
Prognosis